PRESS RELEASE: IVI’s Next Value Assessment Model to Address Major Depressive Disorder Interventions

First of Its Kind Depression Model to be Informed by Input from Diverse Advisory Group September 9, 2020 — Alexandria, VA — The Innovation and Value Initiative (IVI) — a non-profit organization dedicated to advancing the science, practice, and use of value assessment in healthcare — today announced a multi-year initiative to build and test [...]

2020-09-15T13:26:17-06:00September 9th, 2020|IVI News, Press|

IVI and the University of Maryland Pharmacy School’s PAVE Center Partner on Patient-Centered Value Assessment

In an article in The Patient, IVI and the Patient-Driven Values in Healthcare Evaluation (PAVE) Center at the University of Maryland School of Pharmacy describe how they develop methods and models that make patient-centered value assessment both scientifically feasible and relevant to real-world decisions across the range of stakeholders. Read the full article here.

2020-08-28T17:17:34-06:00August 28th, 2020|IVI News, Viewpoints|

Second Webinar in the ISPOR-IVI Series Explores Whether Value Assessments are Up to the Task in the Age of COVID-19

The second part of a five-part webinar series examining value assessment in the COVID-19 era hosted by ISPOR and the Innovation and Value Initiative (IVI) will explore whether the methods on which health economists have relied are up to task or in need of improvement for the pandemic era. Moderated by Lou Garrison, PhD (University [...]

2020-09-09T09:43:29-06:00August 24th, 2020|IVI News|

Jennifer Bright Discusses Her Journey and How to Improve Value Assessment

In an interview with Dr. William Seeds in Authority Magazine, Jennifer Bright talks about her own journey to IVI, what drives her to improve value assessment, and why collaboration is paramount for success. Read the full interview here.

2020-08-11T14:10:05-06:00July 30th, 2020|IVI News|

The Promise of MCDA to Improve Equity in Value Assessment

In a commentary in AJMC, IVI examines how multi-criteria decision analysis has the potential to better understand and assess value for innovative cell and gene therapies which are transforming the lives of patients living with serious diseases. Read the full article here.

2020-08-11T14:06:36-06:00July 26th, 2020|IVI News, Viewpoints|

PRESS RELEASE: IVI Announces Grant to National Health Council, National Alliance of Healthcare Purchaser Coalitions to Improve Value Assessment

Goal: Identify Areas of Consensus to Ultimately Make the Value Assessment Process Useful to Those Who Receive and Pay for Care Alexandria, VA – July 20, 2020 – The Innovation and Value Initiative (IVI), a non-profit research organization dedicated to improving the science and practice of value assessment, announced today it is awarding a grant [...]

2020-07-19T16:21:52-06:00July 20th, 2020|IVI News, Press|

Can Depression Help Employers Improve Their Value Assessment Methods?

IVI's Jennifer Bright and Mike Thompson of the National Alliance for Healthcare Purchasers share how employers can use depression as a "test case" for thinking about how to improve the value assessment process, so that we can apply a "purchaser-patient" lens up front. Read the full article on Employers Benefit News here.

2020-07-15T11:30:30-06:00June 24th, 2020|IVI News, Viewpoints|

Value Assessment During the COVID-19 Pandemic

The COVID-19 pandemic is raising new questions about how we approach value assessment. As always, IVI urges experts to use transparency, real world data, and seek consensus. Sam Nussbaum, President of the IVI Board of Directors, shares his thoughts in a commentary in STAT. Read the full commentary here.

2020-06-30T09:53:00-06:00June 18th, 2020|IVI News|
Go to Top